Stock Research for NLNK


Featured Broker: Ally Invest

Get the due diligence for another stock.


NLNK Stock Chart & Research Data

The NLNK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NLNK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


NLNK Due diligence Resources & Stock Charts

The NLNK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NLNK Detailed Price Forecast - CNN Money CNN View NLNK Detailed Summary - Google Finance
Yahoo View NLNK Detailed Summary - Yahoo! Finance Zacks View NLNK Stock Research & Analysis -

Stock Analysis

TradeIdeas View NLNK Trends & Analysis - Trade-Ideas Barrons View NLNK Major Holders - Barrons
NASDAQ View NLNK Call Transcripts - NASDAQ Seeking View NLNK Breaking News & Analysis - Seeking Alpha
Spotlight View NLNK Annual Report - OTC Report View NLNK OTC Short Report -
TradeKing View NLNK Fundamentals - TradeKing Charts View NLNK SEC Filings - Bar Chart
WSJ View Historical Prices for NLNK - The WSJ Morningstar View Performance/Total Return for NLNK - Morningstar
MarketWatch View the Analyst Estimates for NLNK - MarketWatch CNBC View the Earnings History for NLNK - CNBC
StockMarketWatch View the NLNK Earnings - StockMarketWatch MacroAxis View NLNK Buy or Sell Recommendations - MacroAxis
Bullish View the NLNK Bullish Patterns - American Bulls Short Pains View NLNK Short Pain Metrics -

Social Media Mentions

StockTwits View NLNK Stock Mentions - StockTwits PennyStocks View NLNK Stock Mentions - PennyStockTweets
Twitter View NLNK Stock Mentions - Twitter Invest Hub View NLNK Investment Forum News - Investor Hub
Yahoo View NLNK Stock Mentions - Yahoo! Message Board Seeking Alpha View NLNK Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for NLNK - Insider Cow View Insider Transactions for NLNK - Insider Cow
CNBC View NLNK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NLNK - OTC Markets
Yahoo View Insider Transactions for NLNK - Yahoo! Finance NASDAQ View Institutional Holdings for NLNK - NASDAQ

Stock Charts

FinViz View NLNK Stock Insight & Charts - StockCharts View NLNK Investment Charts -
BarChart View NLNK Stock Overview & Charts - BarChart Trading View View NLNK User Generated Charts - Trading View

Latest Financial News for NLNK

Complimentary Technical Snapshots on OHR Pharma and Three More Biotech Stocks
Posted on Friday July 13, 2018

LONDON, UK / ACCESSWIRE / July 13, 2018 / If you want a free Stock Review on OHRP sign up now at For today, observes Auris Medical Holding AG (EARS), NewLink Genetics Corp. (NLNK), OHR Pharmaceutical Inc. (OHRP), and Omeros Corp. (OMER). The industry includes the manufacturing and marketing of drugs as a result of direct research and development.

NewLink Genetics to Host Its Second Quarter 2018 Financial Results Conference Call on July 31, 2018
Posted on Tuesday July 10, 2018

AMES, Iowa, July 10, 2018-- NewLink Genetics Corporation today announced that it will release its second quarter 2018 financial results on Tuesday, July 31, 2018. The company has scheduled a conference ...

NewLink Genetics Announces Positive Updated Phase 1 Data with Indoximod Plus Radio-Immunotherapy for Pediatric Patients with DIPG Presented at ISPNO 2018
Posted on Monday July 02, 2018

NewLink Genetics Corporation (NLNK), reported that updated Phase 1 data evaluating indoximod plus front-line radiation and maintenance chemotherapy for the treatment of pediatric patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG) were presented Sunday, July 1, at the International Symposium of Pediatric Neuro-Oncology (ISPNO) 2018 Annual Meeting in Denver. Data were presented on ten newly diagnosed DIPG patients, all of whom had initiated therapy at the time of this assessment. “These data continue to demonstrate the potential for indoximod plus radiochemotherapy as a combination treatment regimen which may improve disease related symptoms for these pediatric patients with an otherwise dire prognosis,” said Dr. Theodore S. Johnson, M.D., Ph.D., Associate Professor of Pediatrics at Augusta University, lead investigator for the trial.

The Week Ahead In Biotech: Delayed Clinical Trial Releases In Focus
Posted on Saturday June 30, 2018

Biotech stocks came under pressure earlier in the week, weighed down by negative trial results, mixed FDA verdicts and overall pessimistic broader market sentiment, but recovered in the last two sessions. ...

Enter a stock symbol to view the stock details.